Lyra Therapeutics Inc.

04/17/2026 | Press release | Distributed by Public on 04/17/2026 06:59

Termination of Material Agreement (Form 8-K)

Item 1.02 Termination of a Material Definitive Agreement.

Termination of 880 Winter Street Sublease (Waltham, Massachusetts)

On April 13, 2026, Lyra Therapeutics, Inc. (the "Company") entered into a Termination of Sublease with RVAC Medicines (US), Inc. to terminate the Company's sublease for approximately 23,704 rentable square feet at 880 Winter Street, Waltham, Massachusetts. The sublease, dated December 21, 2023, terminated effective as of March 31, 2026, with the Company required to surrender the premises no later than May 31, 2026.

As consideration, the Company agreed to pay a termination payment of $2,100,000.00. Upon the Company's completion of its surrender obligations and receipt of the termination payment, RVAC will release and return the Company's $600,501.32 letter of credit security deposit. The Company's rent obligations terminated as of January 31, 2026.

Lyra Therapeutics Inc. published this content on April 17, 2026, and is solely responsible for the information contained herein. Distributed via EDGAR on April 17, 2026 at 12:59 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]